BOY.L

Bodycote Plc
Bodycote Plc - Capital Markets Event
12th December 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
[image]

12 December 2024

Bodycote plc

Capital Markets Event

Optimise, Perform, Grow

Bodycote, the world's leading provider of precision heat treatment and
specialist thermal processing services, will today host a Capital Markets Event
for analysts and institutional investors in London.

Jim Fairbairn, Chief Executive Officer and Ben Fidler, Chief Financial Officer
will host the event, with additional presentations from Bodycote's leadership
team. They will set out plans and actions to deliver sustainable improvements in
the quality, performance and growth outlook for the business, as well as setting
new financial targets.

  · New divisional reporting established around two high quality platforms
    · Specialist Technologies and Precision Heat Treatment

  · Three levers of strategic execution:
    · Optimise: create an efficient footprint and operating model
    · Perform: improve operational performance, service quality and
profitability
    · Grow: deliver accelerated, profitable growth

  · Compelling financial targets announced, underpinned by our strategic actions
    · mid-single digit % total revenue growth p.a. through the cycle
    · Specialist Technologies to increase to 35-40% of revenue by 2028
    · operating margins >20% by 2028
    · through-cycle operating cash conversion of 80-90%
    · through-cycle ROCE of 15-20%

  · Rigorous and balanced approach to capital allocation
    · Announcing today our intention to extend the Group's current £60m share
buyback programme by a further £30m

Chief Executive Officer, Jim Fairbairn said:

"Today we are presenting a clear vision to create an optimised, efficient and
high-performance Bodycote, which will deliver sustainably stronger growth with
improved profitability and resilience through the cycle."

"We are establishing a set of compelling and achievable financial targets. We
are confident in our ability to achieve these ambitions and have a clear plan to
deliver on our targets. This will benefit not just our shareholders but our
people, customers and partners. We are building a company that can fully realise
its potential, and ensure that Bodycote's excellence endures long into the
future."

Two high quality platforms - Specialist Technologies and Precision Heat
Treatment

We will drive improved growth and performance from two new, redefined global
divisions:

  · Specialist Technologies will include our Hot Isostatic Pressing (HIP),
Stainless Steel processes (S3P) and Surface Technologies activities. We have
leadership positions in each of these differentiated technologies and our focus
is on expanding our addressable markets to achieve consistent above-market rates
of growth, with strong margins.
  · Precision Heat Treatment includes our operations that provide a range of
leading heat treatment services globally. We will focus on optimising our plant
footprint and driving higher quality, lower carbon, and higher value-add
processes. We see significant potential for sustainably improved margin
performance and further topline growth from this platform.

We will begin reporting on this new basis at our full year 2024 results in March
2025.

Three levers to drive strategic execution

Our plan to deliver Bodycote's full potential from these two leading divisions
will be executed through three principal strategic levers:

  · Optimise: refining our current network of plants to improve performance,
elevate the quality of the portfolio, as well as creating an efficient operating
structure to improve the Group's growth and margin potential.
  · Perform: implementing a focused Group-wide operational improvement programme
to drive performance. The programme, named HEAT, aims to enable a high
performance culture, enhance our service quality, maintain an agile cost base,
and help us transition to a sustainable future.
  · Grow: capitalising on the growth potential inherent in the Group by focusing
on three areas: structural growth markets, Specialist Technologies and faster
growing geographies. Growth will be augmented by delivering on the opportunity
from our customers' requirements to reduce their carbon emissions, and from
inorganic expansion through disciplined capital allocation.

Accelerating via sustainability

Our capabilities enable us to play a meaningful role in the transition to a low
carbon future, which will act as a key accelerator to our strategy. We have
already made significant progress in this area and today are announcing three
new sustainability targets:

  · By 2030, to reduce absolute scope 1 and scope 2 greenhouse gas emissions by
46% versus 2019 levels. This is an increase from our existing SBTi approved
target which we are on track to achieve six years early.
  · Enabling our customers of atmospheric processing to avoid 125,000 tonnes of
CO2e by 2030. This has been externally validated and is aligned with best
practice guidance for avoided emissions accounting.
  · An increase in the proportion of our revenue which supports sustainable end
-use markets and applications to 20% by 2035 (from 7% in 2023).

Ambitious financial targets announced, underpinned by our strategy

Driven by our strategic actions, we are setting out new financial targets for
the Group:

  · Deliver total revenue growth of mid-single digit % p.a. through the cycle,
the majority of which will be delivered through organic growth
  · Specialist Technologies to increase to 35-40% of revenue by 2028 (FY 2023:
28%1)
  · Achieve headline operating margins of >20% by 2028 (FY 2023: 15.9%)
  · Deliver operating cash conversion of 80-90% through the cycle
  · Sustain a through-cycle Return on Capital Employed (ROCE) of 15-20%

1 Specialist Technologies re-defined to exclude Low Pressure Carburising (LPC)
and Corr-I-Dur ® , now reported within Precision Heat Treatment

Capital Allocation and £30m extension of our current share buyback programme

A disciplined approach to capital allocation remains a central element of our
strategy, encompassing organic growth, dividends, acquisitions and additional
shareholder returns when appropriate. Progress has been made year to date on the
£60m share buyback programme. Since the buyback commenced in March 2024, a
cumulative 8.1m shares have been repurchased under the programme for a total
spend to date of £54.4m.

The Group's balance sheet is strong. As disclosed in our 19 November 2024
trading update, net debt (excluding IFRS16 lease liabilities) was £70m at 31
October 2024, equating to leverage of approximately 0.45x net debt/EBITDA.

We see a range of appealing organic investment opportunities to grow the
business in line with our strategy and continue to evaluate acquisition
opportunities as they become available. Our primary focus in the near term is on
the execution and delivery of our plan. Reflecting this focus and the strength
of our balance sheet, we are announcing today our intention to extend our
existing £60m share buyback programme by a further £30m. This will be executed
during 2025.

Financial impact of optimisation actions

We will be undertaking a number of optimisation actions to drive step changes
and improvements across the business. We expect these to deliver an ongoing
annual operating profit benefit of £12-14m, once the programme is complete by
the end of 2026.

The optimisation of our plant footprint and associated plant closures, together
with overhead cost reduction actions, will lead to an exceptional net cash cost
of c. £25-30m. We expect an exceptional P&L charge of c.£60m, with an additional
c.£12-15m goodwill write-down related to our North America Automotive and
Industrial focused operations. The majority of the exceptional P&L charge and
cash costs will be incurred across 2024 and 2025. For a temporary period we will
also be reporting a small non-core division as we progress with the optimisation
programme.

Current trading

Current trading remains in line with that disclosed in our 19 November 2024
trading update, and our full year expectations remain unchanged. The Group will
not be providing any new information on current trading at today's event.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

Post-event recording and presentation

For those unable to attend the in-person event, there will be a post-event
recording available which can be accessed from 17 December 2024 using the
following webcast link: https://www.bodycote.com/investors/capital-markets-event
-2024/

A copy of all the presentation materials will be made available on the Group's
investor relations website from 14.00 on 12 December 2024.

Disclosures:

This announcement contains inside information for the purposes of Article 7 of
Regulation 2014/596/EU which is part of UK domestic law pursuant to the Market
Abuse (Amendment) (EU Exit) Regulations (SI 2019/310) ("UK MAR"). Upon the
publication of this announcement, this inside information (as defined in UK MAR)
is now considered to be in the public domain.

This announcement contains forward-looking statements based on current
expectations and assumptions. Various known and unknown risks, uncertainties and
other factors may cause actual results to differ from future results or
developments expressed or implied from the forward-looking statements. Each
forward-looking statement speaks only as of the date of this document. Bodycote
plc accepts no obligation to revise or update these forward-looking statements
publicly or adjust them to future events or developments, whether as a result of
new information, future events or otherwise, except to the extent legally
required.

This information was brought to you by Cision http://news.cision.com

TwitterFacebookLinkedIn